"Quality of Life Promotional Claims: Methodological Issues and Potential Solutions"
co-sponsored by
ISPOR and PhRMA Health Outcomes Committee and the US Food and Drug Administration
Supported by funding from:
Aventis Pharmaceuticals
Bristol-Myers Squibb
Eli Lilly and Company
Glaxo Wellcome Inc.
Johnson & Johnson Health Economics
Merck Research Laboratories
Novartis Pharmaceuticals
Parke Davis Pharmaceutical Research
Pharmacia
Pfizer Inc.
Pharmaceutical Research Manufacturers Association [PhRMA]
